Provided by Tiger Fintech (Singapore) Pte. Ltd.

Oramed Pharmaceuticals

2.13
-0.0200-0.93%
Post-market: 2.130.00000.00%16:06 EDT
Volume:96.72K
Turnover:203.08K
Market Cap:87.01M
PE:-3.00
High:2.17
Open:2.13
Low:2.06
Close:2.15
Loading ...

Oramed Pharmaceuticals Inc - Extends Stock Buyback Program for One Year - SEC Filing

THOMSON REUTERS
·
22 May

Alpha Tau Medical Ltd. Reports First Quarter 2025 Financial Results; Cash and Equivalents Decrease to $54.8 Million, Raises $36.9 Million in April Financing

Reuters
·
20 May

Alpha Tau Medical Ltd. Appoints Nadav Kidron to Board of Directors Amid Strategic Investment with Oramed

Reuters
·
13 May

Oramed Completes $36.9 Million Strategic Investment in Alpha Tau Medical

MT Newswires Live
·
28 Apr

BRIEF-Oramed Pharmaceuticals Announces $36.9 Million Investment And Strategic Collaboration With Alpha Tau Medical

Reuters
·
28 Apr

Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration With Alpha Tau Medical

THOMSON REUTERS
·
28 Apr

Alpha Tau Announces Closing of $36.9 Million Registered Direct Offering and Strategic Marketing Alliance with Oramed Pharmaceuticals

GlobeNewswire
·
28 Apr

Press Release: Oramed Pharmaceuticals Announces $36.9 Million Investment and Strategic Collaboration with Alpha Tau Medical

Dow Jones
·
28 Apr

ORMP: Upcoming Expected Milestones Include OraTech Spin-Off & IPO, Launch of Phase 3 Trial

Zacks Small Cap Research
·
03 Apr

Oramed Pharmaceuticals Inc expected to post a loss of 2 cents a share - Earnings Preview

Reuters
·
22 Mar

Oramed Pharmaceuticals Inc expected to post a loss of 2 cents a share - Earnings Preview

Reuters
·
18 Mar

Oramed Pharmaceuticals And 2 Other Penny Stocks With Promising Potential

Simply Wall St.
·
14 Mar

Oramed Pharmaceuticals Inc expected to post a loss of 2 cents a share - Earnings Preview

Reuters
·
11 Mar

Oramed Pharmaceuticals Inc expected to post a loss of 2 cents a share - Earnings Preview

Reuters
·
06 Mar

Oramed Pharmaceuticals Issues Letter to Shareholders

PR Newswire
·
04 Mar

Oramed Pharmaceuticals Inc expected to post a loss of 2 cents a share - Earnings Preview

Reuters
·
01 Mar

Oramed Pharmaceuticals And 2 Other US Penny Stocks To Watch

Simply Wall St.
·
12 Feb

Oramed Pharmaceuticals Forms Joint Venture to Commercialize Oral Insulin; Shares Rise

MT Newswires Live
·
12 Feb

Oramed enters JV for insulin development and commercialization

TIPRANKS
·
11 Feb

BRIEF-Oramed Announces Joint Venture To Develop And Commercialize Oral Insulin

Reuters
·
11 Feb